‘Material uncertainty’ plagues state-backed Nektr Technologies as losses rise to €2.1m

2022 accounts for Sligo-based biotech firm, founded by Frank Boyle, ‘cast significant doubt’ on its ‘ability to continue’

Frank Boyle, Nektr founder and chief executive: Nektr was founded by Boyle in 2017 after he sold his previous business, ProTek Medical, to Molex for a figure estimated €25 million. Picture: James Connolly